Clinical Trials Sponsored by American Genomics, LLC

Total 121 results

American Genomics, LLC

Completed

A Safety Study of of AG-920 Sterile Topical Ophthalmic Solution

Anesthesia, Local

United States
American Genomics, LLC

Completed

A Study of Safety and the Local Anesthetic Effect of AG-920 Ophthalmic Solution in a Pediatric Population

Anesthesia, Local

United States
American Genomics, LLC

Completed

A Study of the Safety and Anesthetic Effect of AG-920 Topical Ophthalmic Solution

Anesthesia, Local

United States
American Genomics, LLC

Completed

A Study of the Safety and Anesthetic Effect of AG-920 Topical Ophthalmic Solution

Anesthesia, Local

United States
American Genomics, LLC

Completed

An Open Label, Study of the Systemic Exposure to Articaine After Topical Ocular Dosing of AG-920

Healthy

United States
Global Genomics Group, LLC

Unknown

GLOBAL Clinical Study (GLOBAL)

Coronary Artery Disease

United Kingdom, United States, Hungary, Netherlands, Australia, Germany, Poland, Canada, Croatia
Genomind, LLC

Completed

An Open Label Study of Clinical Utility and Patient Outcomes of the Genecept Assay (COM-1)

Generalized Anxiety Disorder | Treatment Resistant Depression

United States
Genomind, LLC

Withdrawn

An Open Label Study of the Genecept™ Assay in Treatment Resistant Depression

Major Depressive Disorder

United States
Genomind, LLC

Terminated

Pharmacogenomics for Antidepressant Guidance and Education 1 (PAGE-1_AG1) (PAGE-1_AG1)

Major Depressive Disorder

United States
Żelazna Medical Centre, LLC
Laboratory of Genetics and Human Genomics, University of Gdańsk

Completed

Genetic Aspects of Vaginal Aging

Genitourinary Agents

Poland
American BioOptics, LLC

Unknown

Colon Cancer Risk-stratification Via Optical Analysis of Rectal Ultrastructure

Colon Cancer

United States
Northwell Health
Genomind, LLC

Completed

Prospective Pharmacogenetic Testing and Clinical Outcomes in Patients With Early-Phase Psychosis

Psychotic Disorders | Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder | Bipolar Disorder

United States
Mclean Hospital
Genomind, LLC

Completed

McLean and Genomind Prospective Study (GPS)

PTSD | Major Depressive Disorder

United States
Genomind, LLC
Medpace, Inc.

Completed

Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD

Major Depressive Disorder

United States
Kaneka Medical America LLC

Recruiting

Kaneka Endovascular Embolization and Protection (KEEP)

Aneurysm Cerebral

United States
Implantcast North America, LLC

Not yet recruiting

Prospective Post-market Study Examining the Effectiveness of the EcoFit®

Femoral Fracture | Osteoarthritis, Hip | Traumatic Arthritis | Degenerative Joint Disease
Kaneka Medical America LLC

Recruiting

Post Approval Study of Lixelle for the Treament of Dialysis-Related Amyloidosis

Dialysis Amyloidosis

United States
Kaneka Medical America LLC

Recruiting

Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children (FSGS pediatric)

Focal Segmental Glomerulosclerosis

United States
Kaneka Medical America LLC

Recruiting

Post Approval Study for Treatment of Drug-resistant Adult and Pediatric Primary FSGS Using the LIPOSORBER® LA-15 System (FSGSALLAGE)

Focal Segmental Glomerulosclerosis

United States
Mercer University
Merck Sharp & Dohme LLC; Emory University; Celera Genomics

Completed

Study of Cholesterol Levels and Types in African Americans With Type 2 Diabetes (LAAD)

Type 2 Diabetes | Cholesterol | African American | Lipoprotein | Apolipoprotein

United States
American Cancer Society, Inc.
Will2Love, LLC

Completed

The Find Your PATHS (Pragmatic Assessment of a Tool to Help Survivors) to Sexual Health and Parenthood Study (PATHS)

Fertility | Sexuality | Cancer-related Problem/Condition

United States
Sucampo Pharma Americas, LLC

Completed

Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone

Opioid-Induced Bowel Dysfunction

United States, Canada
Sucampo Pharma Americas, LLC

Terminated

Cobiprostone for the Prevention of Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concurrent Radiation and Chemotherapy

Oral Mucositis

United States
Sucampo Pharma Americas, LLC

Completed

Cobiprostone Prevention of NSAID-induced Gastroduodenal Injury

Osteoarthritis | Rheumatoid Arthritis | Ulcers | NSAID-induced Gastroduodenal Injury

United States
Institute for Human Genetics and Biochemistry
Grifols Biologicals, LLC; AIDS Community Research Initiative of America

Terminated

Safety and Efficacy of (α1Proteinase Inhibitor, α1PI) in HIV Disease

HIV Disease

United States
Genomics PLC
NHS North of England Commissioning Support (NECS)

Completed

The Healthcare Evaluation of Absolute Risk Testing Study (HEART)

Cardiovascular Diseases

United Kingdom
Rocky Vista University, LLC
American Osteopathic Association

Enrolling by invitation

Quantitative Ultrasound Biomarkers to Assess Upper Trapezius Muscles in Patients With Chronic Pain

Chronic Neck Pain

United States
American Laboratory Products Company
MDC Associates, LLC

Completed

ALPCO Calprotectin ELISA - Measurement of Calprotectin Levels in Human Stool

Irritable Bowel Syndrome | Inflammatory Bowel Diseases

United States
Sucampo Pharma Americas, LLC
Takeda

Completed

Lubiprostone for Children With Constipation

Constipation - Functional

United States, United Kingdom, Netherlands, Poland, Belgium, France, Canada
Sucampo Pharma Americas, LLC
Takeda

Completed

Efficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With Constipation

Irritable Bowel Syndrome With Constipation
Sucampo Pharma Americas, LLC
Takeda

Completed

Comparative Pharmacokinetics and Food-Effect Bioavailability of Lubiprostone Sprinkle in Healthy Volunteers

Healthy Volunteers

United States
Sumitomo Pharma America, Inc.
BehaVR LLC

Completed

A Randomized, Controlled Study of Two At-Home Self-Guided Virtual Reality Interventions for Adults With Social Anxiety Disorder. (BVR-100-102)

Social Anxiety Disorder (SAD)

United States
Emory University
Kaneka Medical America LLC

Completed

Effects of Low-density Lipoprotein (LDL) Apheresis on Inflammatory and Lipid Markers (INFLAME)

Familial Hypercholesterolemia

United States
Translational Genomics Research Institute
Merck Sharp & Dohme LLC; Stand Up To Cancer

Completed

A SU2C Catalyst® Trial of a PD1 Inhibitor With or Without a Vitamin D Analog for the Maintenance of Pancreatic Cancer

Pancreatic Cancer | Pancreas Adenocarcinoma | Metastatic Pancreatic Adenocarcinoma | Metastatic Pancreatic Cancer | Advanced Pancreatic Cancer

United States
Aevi Genomic Medicine, LLC, a Cerecor company

Completed

Safety and Efficacy Study of NFC-1 in Subjects Aged 12-17 Years With 22q11.2DS & Associated Neuropsychiatric Conditions

22q11.2 Deletion Syndrome

United States
Aevi Genomic Medicine, LLC, a Cerecor company

Completed

Efficacy and Safety of NFC-1 in Adolescents With Genetic Disorders Impacting mGluR and ADHD

Attention Deficit Disorder With Hyperactivity

United States
Aevi Genomic Medicine, LLC, a Cerecor company

Completed

PART B: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and Without mGluR Mutations

Attention Deficit Hyperactivity Disorder

United States
Aevi Genomic Medicine, LLC, a Cerecor company

Completed

A Non-interventional Study to Identify Children and Adolescents With ADHD and With or Without mGLuR Mutations

Attention Deficit Hyperactivity Disorder

United States
Aevi Genomic Medicine, LLC, a Cerecor company

Completed

Clinical Trial to Evaluate CERC-002 in Adults With COVID-19 Pneumonia and Acute Lung Injury

Acute Lung Injury | ARDS | COVID-19 Pneumonia

United States
Aevi Genomic Medicine, LLC, a Cerecor company

Completed

PART A: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and With mGluR Mutations

Attention Deficit Hyperactivity Disorder

United States
Aevi Genomic Medicine, LLC, a Cerecor company

Completed

Pharmacokinetic and Tolerability Study of NFC-1 in Subjects Aged 6-17 Years With ADHD

Attention Deficit Disorder With Hyperactivity

United States
Aevi Genomic Medicine, LLC, a Cerecor company

Completed

A Noninterventional Genotype/Phenotype Study of mGluR Mutations in Children and Adolescents With ADHD

Attention Deficit Disorder With Hyperactivity

United States
Seattle Institute for Biomedical and Clinical Research
Genomind, LLC

Active, not recruiting

Medication Optimization Using Pharmacogenetic Testing and the G-DIG to Reduce Polypharmacy in a Mental Health Population (MedOPT)

Pharmacogenetic Testing

United States
Loma Linda University
MeriCal LLC

Completed

Probiotics, Immunity, Stress, and QofL

Quality of Life | Stress

United States
Aevi Genomic Medicine, LLC, a Cerecor company
Medgenics Medical Israel Ltd.

Terminated

TARGTEPO Treatment for Anemia in End Stage Renal Disease (ESRD) Patients Undergoing Peritoneal Dialysis (PD)

Anemia of End Stage Renal Disease

Israel
Sucampo Pharma Americas, LLC
Sucampo AG

Completed

Evaluation of the Safety of Lubiprostone in Pediatric Participants Aged ≥ 6 Years to < 18 Years With Functional Constipation

Constipation - Functional

United States
Bausch Health Americas, Inc.
Valeant Russia, LLC

Completed

Safety and Efficacy of Neuromultivit in Treatment of Vertebrogenic Radiculopathy (NMRUS)

Vertebrogenic Radiculopathy L5, S1

Russian Federation
Sucampo Pharma Americas, LLC
Sucampo AG

Completed

Lubiprostone in Children With Functional Constipation

Constipation - Functional

United States, United Kingdom, Canada, Netherlands, Poland, Belgium, France
Aevi Genomic Medicine, LLC, a Cerecor company
Medgenics Medical Israel Ltd.

Completed

TARGTEPO Treatment for Anemia in Chronic Kidney Disease (CKD) Patients and End-Stage Renal Disease (ESRD)

End Stage Renal Disease | Chronic Kidney Disease

Israel
Massachusetts General Hospital
Kaneka Medical America LLC

Completed

Removal of Anti-Angiogenic Proteins in Preeclampsia Before Delivery (RAAPID-II)

Preeclampsia

Germany, United States

Clinical Trials Sponsored by American Genomics, LLC

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Luxembourg

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations